Clinical presentation of sarcoidosis in the Netherlands. An epidemiological study

Netherlands Journal of Medicine

Volumn 53, Issue 2, 1998, Pages 53-60

  Wirnsberger, R M ^a   De Vries, J ^b   Wouters, E F M ^a   Drent, M ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b TILBURG UNIVERSITY   (Netherlands)

Author keywords

Dutch population; Epidemiology; Sarcoidosis; Symptoms

Indexed keywords

CORTICOSTEROID;

ADULT; ARTHRALGIA; ARTICLE; CLINICAL FEATURE; COPING BEHAVIOR; DYSPNEA; FATIGUE; FEMALE; HEALTH; HUMAN; MAJOR CLINICAL STUDY; MALE; MYALGIA; NETHERLANDS; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; SARCOIDOSIS; SOCIAL PSYCHOLOGY; SYMPTOM; THORAX PAIN; TUBERCULOSIS;

ADULT; AGE DISTRIBUTION; AGE OF ONSET; AGED; ARTHRITIS, RHEUMATOID; CHI-SQUARE DISTRIBUTION; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NETHERLANDS; QUESTIONNAIRES; RISK FACTORS; SARCOIDOSIS; SEX DISTRIBUTION; SOFTWARE; SURVIVAL RATE; TUBERCULOSIS;

EID: 0031823927     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-2977(98)00058-8     Document Type: Article

References (37)

1. Thomas PD, Hunninghake GW. Current concepts of the pathogenesis of sarcoidosis. Am Rev Respir Dis 1987;135:747-760.
2. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med 1997;336:1224-1234.
3. James DG. Complications of sarcoidosis. Chronic fatigue syndrome. Sarcoidosis 1993;10:1-3.
4. Costabel U, du Bois R, Eklund A, et al. Consensus conference: activity of sarcoidosis. Third WASOG meeting, Los Angeles, USA, September 8-11, 1993. Eur Respir J 1994;7:624-627.
5. Costabel U, du Bois R, Eklund A, et al. Consensus conference: activity of sarcoidosis. Third WASOG meeting, Los Angeles, USA, September 8-11, 1993. Eur Respir J 1994;7:624-627.
6. McSweeny AJ, Grant I, Heaton RK, Adams KM, Timms RM. Life quality of patients with chronic obstructive pulmonary disease. Arch Intern Med 1982;142:473-478.
7. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992;145:1321-1327.
8. Schrier AC, Dekker FW, Kaptein AA, Dijkman JH. Quality of life in elderly patients with chronic nonspecific lung disease seen in family practice. Chest 1990;98:894-899.
9. Renwick DS, Connolly MJ. Impact of obstructive airways disease on quality of life in older adults. Thorax 1996;51:520-525.
10. Okubadejo AA, Jones PW, Wedzicha JA. Quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia. Thorax 1996;51:44-47.
11. Maillé AR, Koning CJM, Zwinderman AH, Willems LNA, Dijkman JH, Kaptein AA. The development of the Quality-Of-Life for Respiratory Illness Questionnaire (QOL-RIQ): a disease-specific quality-of-life questionnaire for patients with mild to moderate chronic non-specific lung disease. Respir Med 1997;91:297-309.
12. Wirnsberger RM, Drent M, Hekelaar N, et al. Relationship between respiratory muscle function and quality of life in sarcoidosis. Eur Respir J 1997;10:1450-1455.
13. Drent M, Wirnsberger RM, Breteler MHM, Kock LMM, de Vries J, Wouters EFM. Quality of life and depressive symptoms in patients suffering from sarcoidosis. Sarcoidosis Vase Diffuse Lung Dis 1998;15:59-66.
14. James DG. Epidemiology of sarcoidosis. Sarcoidosis 1992;9:79-87.
15. Pietinalho A, Ohmichi M, Hiraga Y, Löfroos A-B, Selroos O. The mode of presentation of sarcoidosis in Finland and Hokkaido, Japan. A comparative analysis of 571 Finnish and 686 Japanese patients. Sarcoidosis 1996;13:159-166.
16. Hillerdal G, Nöu E, Osterman K, Schmekel B. Sarcoidosis: epidemiology and prognosis. A 15-year European study. Am Rev Respir Dis 1984;130:29-32.
17. WHOQOL group. Field trial WHOQOL-100 February 1995, facet definitions and questions. 1995a, Geneva: WHO (MNH/PSF/95.1.B).
18. Ray C, Weir WRC, Phillips S, Cullen S. Development of a measure of symptoms in chronic fatigue syndrome: The Profile of Fatigue-Related Symptoms (PFRS). Psychol Health 1992;7:27-43.
19. Drent M, Schols AMWJ, Wouters EFM. Alterations in metabolism and body composition associated with an acute phase response in patients suffering from sarcoidosis. Sarcoidosis 1997;14:43. suppl 1.
20. Jamal MM, Cilursu AM, Hoffman EL. Sarcoidosis presenting as acute myositis. Report and review of the literature. J Rheumatol 1988;15:1868-1871.
21. Silverstein A, Siltzbach LE. Muscle involvement in sarcoidosis: asymptomatic, myositis, and myopathy. Arch Neurol 1969;21:235-241.
22. du Bois RM. Sarcoidosis. In: Walters EH, du Bois RM, editors. Immunology and Management of Interstitial Lung Diseases. London: Chapman and Hall, 1995;97-122.
23. Fité E, Alsina JM, Mañá J, Pujol R, Ruiz J, Morera J. Epidemiology of sarcoidosis in Catalonia: 1979-1989. Sarcoidosis 1996;13:153-158.
24. Harrington DW, Major M, Rybicki B, Popovich J, Maliarik M, Iannuzzi MC. Familial sarcoidosis: analysis of 91 families. Sarcoidosis 1994;11:240-243.
25. Kirsten D. Sarkoidose in Deutschland. Analyse einer Fragebogenaktion im Jahre 1992 bei Patienten der Deutschen Sarkoidose Vereinigung. Pneumologie 1995;49:378-382.
26. Johard U, Berlin M, Eklund A. Sarcoidosis and regional enteritis in two patients. Sarcoidosis 1996;13:50-53.
27. Grönhagen-Riska C, Fyhrquist F, Hortling L, Koskimies S. Familial occurrence of sarcoidosis and Crohn's disease. Lancet 1983;1:1287-1288.
28. Hansell DM. High resolution computed tomography in sarcoidosis and extrinsic allergic alveolitis: imaging insights. Sarcoidosis 1992;9:21-28.
29. Drent M, Van Nierop MAMF, Gerritsen FA, Wouters EFM, Mulder PGH. A computer program using BALF-analysis results as a diagnostic tool in interstitial lung diseases. Am J Respir Crit Care Med 1996;153:736-741.
30. Hunninghake GW, Gilbert S, Pueringer R, et al. Outcome of the treatment for sarcoidosis. Am J Respir Crit Care Med 1994;149:893-898.
31. Gibson GJ, Prescott RJ, Muers MF, et al. British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment. Thorax 1996;51:238-247.
32. Gottlieb JE, Israel HL, Steiner RM, Triolo J, Patrick H. Outcome in sarcoidosis. The relationship of relapse to corticosteroid therapy. Chest 1997;111:623-631.
33. Eule H, Weinecke A, Roth I. The possible influence of corticosteroid therapy on the natural course of pulmonary sarcoidosis. Ann NY Acad Sci 1986;465:695-701.
34. Kirsten D. Inhaled steroids for sarcoidosis? Editorial. Eur Respir J 1995;8:679-681.
35. Kirsten D, Nowak D, Pielesch W, Magnussen H. Hyperreaktivität und obstruktive Ventilationsstörung bei Lungensarkoidose. Pneumologie 1992;46:278-279.
36. Dutch Study Group on Pulmonary Sarcoidosis, Alberts C, Van der Mark ThW, Jansen HM. Inhaled budesonide in pulmonary sarcoidosis: a double blind, placebo-controlled study. Eur Respir J 1995;8:682-688.
37. Baughman RP, Lower EE. Alternatives to corticosteroids in the treatment of sarcoidosis. Sarcoidosis 1997;14:121-130.